Clonal Memory Diverges in AML

Company Institut Curie Event Type Published Research (Peer-Reviewed, Nature Communications) Modality Single-cell lineage tracking platform Asset Multigenerational HSPC division-memory measurement platform (research-stage, not a named clinical asset) Target Inherited division timing and fate-commitment programs in hematopoietic stem and progenitor cells Disease Area Acute myeloid leukemia…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *